Modha J, Doenhoff M J
Department of Biochemistry, University of Glasgow.
Parasitology. 1994 Nov;109 ( Pt 4):487-95. doi: 10.1017/s0031182000080744.
Contrapsin, a serine protease inhibitor (serpin) present in mouse serum, was compared with that found in adult Schistosoma mansoni worm homogenates, which although immunologically identical to contrapsin in mouse serum, had a higher molecular weight in Western blotting. Immunolocalization studies demonstrated parasite-associated contrapsin on the surface and interstitial cells of adult male worms. After extraction of these parasites with Triton X-114, contrapsin was found in the aqueous phase of the detergent, suggesting it is unlikely to be an integral membrane protein. Treatment of adult worms with deoxycholate resulted in a change in the electrophoretic behaviour of worm-derived contrapsin. Parallel studies with trypsin suggested this was due to interaction of the serpin with a protease. Using porcine pancreatic trypsin as a model for a putative schistosome protease reacting with contrapsin, we have shown that trypsin, following complex formation with contrapsin, loses immunogenicity. Thus, when contrapsin-trypsin complexes were used as immunogen, the resulting antisera contained antibodies to contrapsin and contrapsin-trypsin complexes only, and none to native trypsin. Thus, epitopes characterizing native trypsin were presumably either masked following complex formation with contrapsin, or their processing and presentation to antigen presenting cells was suppressed, so that an antibody response was not mounted against them. These observations encourage speculation that S. mansoni may be elaborating an immune evasion strategy whereby immunologically sensitive proteases are first complexed with host serpins, which would render them immunogenically inert, and then cleared from the circulation by the host's reticulo-endothelial system. In this way the immune system would be unable to 'see' sensitive parasite proteases sufficiently to mount a response against the parasite.
抗胰蛋白酶是一种存在于小鼠血清中的丝氨酸蛋白酶抑制剂(丝氨酸蛋白酶抑制剂),将其与曼氏血吸虫成虫匀浆中的抗胰蛋白酶进行了比较。曼氏血吸虫成虫匀浆中的抗胰蛋白酶虽然在免疫学上与小鼠血清中的抗胰蛋白酶相同,但在蛋白质印迹法中分子量更高。免疫定位研究表明,成虫雄虫的表面和间质细胞存在与寄生虫相关的抗胰蛋白酶。用Triton X-114提取这些寄生虫后,在去污剂的水相中发现了抗胰蛋白酶,这表明它不太可能是一种整合膜蛋白。用脱氧胆酸盐处理成虫会导致虫源抗胰蛋白酶的电泳行为发生变化。与胰蛋白酶的平行研究表明,这是由于丝氨酸蛋白酶抑制剂与一种蛋白酶相互作用所致。以猪胰蛋白酶作为与抗胰蛋白酶反应的假定血吸虫蛋白酶模型,我们发现,胰蛋白酶与抗胰蛋白酶形成复合物后会失去免疫原性。因此,当抗胰蛋白酶-胰蛋白酶复合物用作免疫原时,产生的抗血清仅含有针对抗胰蛋白酶和抗胰蛋白酶-胰蛋白酶复合物的抗体,而没有针对天然胰蛋白酶的抗体。因此,表征天然胰蛋白酶的表位可能在与抗胰蛋白酶形成复合物后被掩盖,或者其加工和呈递给抗原呈递细胞的过程受到抑制,从而无法引发针对它们的抗体反应。这些观察结果促使人们推测,曼氏血吸虫可能正在制定一种免疫逃避策略,即首先使免疫敏感的蛋白酶与宿主丝氨酸蛋白酶抑制剂形成复合物,使其失去免疫原性,然后由宿主的网状内皮系统从循环中清除。通过这种方式,免疫系统将无法充分“看到”敏感的寄生虫蛋白酶,从而无法对寄生虫产生反应。